Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 1-36 (IGLV1-36) is a protein-coding gene segment in the variable region of human immunoglobulin lambda light chains, located on chromosome 22. It encodes one of the multiple variant sequences B cells use to form the antigen-binding site of antibodies, critical for immune recognition and specificity. This gene undergoes V–J recombination in B lymphocyte development, pairing with joining (J) and constant (C) regions to produce functional antibodies. The variable domain encoded by IGLV1-36, when expressed as part of a complete immunoglobulin molecule, contributes to the diverse antibody repertoire required for effective immune response against pathogens and foreign antigens. However, as a germline gene segment, IGLV1-36 is not a direct therapeutic target itself but forms part of the broader antibody landscape essential for humoral immunity[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 1-36 (IGLV1-36).